H
Hugo N Catalano
Researcher at University of Buenos Aires
Publications - 30
Citations - 737
Hugo N Catalano is an academic researcher from University of Buenos Aires. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 8, co-authored 27 publications receiving 369 citations.
Papers
More filters
Journal ArticleDOI
Prognostic Factors for Severity and Mortality in Patients Infected with COVID-19: A Systematic Review
Ariel Izcovich,Martín Ragusa,Fernando Tortosa,María Andrea Lavena Marzio,Camila Agnoletti,Agustín Bengolea,Agustina Ceirano,Federico Espinosa,Ezequiel Alvarez Saavedra,Verónica Sanguine,Alfredo Tassara,Candelaria Cid,Hugo N Catalano,Arnav Agarwal,Farid Foroutan,Gabriel Rada +15 more
TL;DR: In this article, a systematic review is conducted to identify prognostic factors that may be used in decision-making related to the care of patients infected with SARS-CoV-2.
Journal ArticleDOI
Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
TL;DR: Moderate-quality evidence suggests that daily use of oral finasteride increases hair count and improves patient and investigator assessment of hair appearance, while increasing the risk of sexual dysfunction.
Posted ContentDOI
Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol
Ariel Izcovich,Martín Ragusa,Verónica Sanguine,Fernando Tortosa,Federico Espinosa,Camila Agnoletti,María Andrea Lavena Marzio,Agustín Bengolea,Ezequiel Saavedra,Hugo N Catalano,Gabriel Rada +10 more
TL;DR: A living, web-based version of this review will be openly available during the COVID-19 pandemic and the results will be widely disseminated via peer-reviewed publications, social networks and traditional media.
Journal ArticleDOI
Colonic preparation before colonoscopy in constipated and non-constipated patients: A randomized study
Lisandro Pereyra,Daniel G. Cimmino,Carlos González Malla,Mariano Laporte,Nicolas A. Rotholtz,Carlos Peczan,Sandra Lencinas,Silvia C. Pedreira,Hugo N Catalano,Luis A. Boerr +9 more
TL;DR: In non-constipated patients, compliance is higher with NaP preparations, and bisacodyl is related to adverse effects, and in constipate patients NaP plus bisacODYl is the most effective preparation.
Journal ArticleDOI
Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis
Federico Popoff,Giselle Balaciano,Ariel Bardach,Daniel Comandé,Vilma Irazola,Hugo N Catalano,Ariel Izcovich +6 more
TL;DR: For adult patients with AMI, omega 3 fatty-acids probably yield no benefit to patient important outcomes and there is probably little or no difference in the outcome suspension due to adverse events.